The Journal of Cell Biology · 2014 · 41 citations · 52 references
MedicineCancer BiologyOncologyCarcinogenesisMolecular OncologyTumor ProgressionCancer MetabolismCellular AgingCellular SenescenceMalignant NeoplasmsOncogene-induced SenescenceProtein DegradationCancer Cell SenescenceCellular Senescence BypassNeoplastic ProgressionSenescenceSenescence Bypass MechanismsUbiquitin-mediated DegradationUbiquitin-mediated ProteolysisWarburg Effect
Despite the well-documented clinical significance of the Warburg effect, it remains unclear how the aggressive glycolytic rates of tumor cells might contribute to other hallmarks of cancer, such as bypass of senescence. Here, we report that, during oncogene- or DNA damage-induced senescence, Pak1-mediated phosphorylation of phosphoglycerate mutase (PGAM) predisposes the glycolytic enzyme to ubiquitin-mediated degradation. We identify Mdm2 as a direct binding partner and ubiquitin ligase for PGAM in cultured cells and in vitro. Mutations in PGAM and Mdm2 that abrogate ubiquitination of PGAM restored the proliferative potential of primary cells under stress conditions and promoted neoplastic transformation. We propose that Mdm2, a downstream effector of p53, attenuates the Warburg effect via ubiquitination and degradation of PGAM.
52
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
The limited in vitro lifetime of human diploid cell strains
Leonard Hayflick · Experimental Cell Research · 1965 · 5.8K citations
Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a
Manuel Serrano, Athena W. Lin, Mila E. McCurrach et al. · Cell · 1997 · 5.1K citations · Full text
Medicine, Cell Biology, Oncology +10